Plasma Cell Neoplasms
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 trial to assess safety and efficacy of HDP-101 in Chinese patients with relapsed or refractory multiple myeloma, currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of Ninlaro in Real World Clinical Practice in China
A completed real-world study evaluating Ninlaro (ixazomib) in Chinese clinical practice for multiple myeloma. The study analyzes how the dru…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms [EARLY_Phase 1]
ClinicalTrials.gov entry for an early phase 1 study of CAR19BCMA CAR-T cells for relapsed or refractory plasma cell neoplasms. The trial is …
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Longitudinal Data Registry of Plasma Cell Dyscrasia
This entry describes a longitudinal data registry study of plasma cell dyscrasias, including multiple myeloma, sponsored by Shanghai Zhongsh…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]
A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hemat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with busulfan and fludarabine, with or without antithymocyte globulin, followed by d…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating rasburicase to prevent graft-versus-host disease in patients undergoing donor stem cell transplantation; the stud…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Phase 3]
Phase 3 trial evaluating cyclosporine eye drops to prevent eye graft-versus-host disease in patients after donor stem cell transplant for he…
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment [Phase 1]
Phase 1 trial evaluating total marrow and total lymph node irradiation with fludarabine and melphalan followed by donor stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
SWOG's S0334 trial, which analyzes chromosomal abnormalities in patients with newly diagnosed multiple myeloma and other blood diseases, has…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer [Phase 1]
Phase 1 clinical trial update reporting the completion of a study of EMD 121974 in patients with various locally advanced or metastatic canc…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
The clinical trial evaluating blood stem cell transplants in adults and children with various hematologic cancers, sponsored by Columbia Uni…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 study evaluating liposomal doxorubicin, bortezomib, and dexamethasone in newly diagnosed multiple myeloma; the current trial statu…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood and placental blood transplantation for hematologic cancers or aplastic anemia. The s…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation [Phase 1]
Phase 1 study of a partially HLA-matched irradiated allogeneic cellular therapy given after reduced-intensity total body irradiation; the tr…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Rituximab in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating rituximab for multiple myeloma and related plasma cell neoplasms has completed.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating arsenic trioxide, ascorbic acid, dexamethasone, and thalidomide in multiple myeloma has been withdrawn. The study…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [Phase 2]
A phase 2 clinical trial evaluating a biological therapy after chemotherapy and peripheral stem cell transplantation in patients with variou…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [Phase 1, Phase 2]
This Phase 1/2 trial evaluates a combination chemotherapy regimen followed by peripheral stem cell transplantation in patients with refracto…
-
CLINICAL_TRIALS withdrawal · 2012-10-02Clinical Trial Update: Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 study of busulfan and fludarabine conditioning before donor stem cell transplant for hematologic cancers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial assessing T-cell-depleted allogeneic stem cell transplantation after immunoablative induction chemotherapy and reduced-intensi…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma [Phase 1]
A Phase 1 clinical trial update evaluating the combination of antithymocyte globulin and sirolimus in patients with relapsed multiple myelom…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer [Phase 2]
This is a Phase II clinical trial evaluating an umbilical cord blood transplant using fludarabine, melphalan, and anti-thymocyte globulin in…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 clinical trial results for a cyclophosphamide, bortezomib, and dexamethasone regimen in newly diagnosed multiple myeloma are reporte…